{"id":"https://openalex.org/W2171041379","doi":"https://doi.org/10.1038/sj.bjc.6601879","title":"Hormonal impact of the 17\u03b1-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer","display_name":"Hormonal impact of the 17\u03b1-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer","publication_year":2004,"publication_date":"2004-05-18","ids":{"openalex":"https://openalex.org/W2171041379","doi":"https://doi.org/10.1038/sj.bjc.6601879","mag":"2171041379","pmid":"https://pubmed.ncbi.nlm.nih.gov/15150570","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2409523"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6601879","doi":"https://doi.org/10.1038/sj.bjc.6601879","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6601879","pdf_url":"https://www.nature.com/articles/6601879.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6601879.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105675934","display_name":"Anne E. O\u2019Donnell","orcid":"https://orcid.org/0009-0006-8066-3518","observed_orcids":["https://orcid.org/0009-0006-8066-3518"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A O'Donnell","raw_affiliation_strings":["Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK","Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038"]},{"raw_affiliation_string":"Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053304892","display_name":"Ian Robert Judson","orcid":"https://orcid.org/0000-0002-4766-5304","observed_orcids":["https://orcid.org/0000-0002-4766-5304"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"I Judson","raw_affiliation_strings":["CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057689412","display_name":"Mitch Dowsett","orcid":"https://orcid.org/0000-0003-4122-744X","observed_orcids":["https://orcid.org/0000-0003-4122-744X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Dowsett","raw_affiliation_strings":["Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058014829","display_name":"Florence I. Raynaud","orcid":"https://orcid.org/0000-0003-0957-6279","observed_orcids":["https://orcid.org/0000-0003-0957-6279"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F Raynaud","raw_affiliation_strings":["CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025921361","display_name":"David Paul Dearnaley","orcid":"https://orcid.org/0000-0002-3954-2806","observed_orcids":["https://orcid.org/0000-0002-3954-2806"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D Dearnaley","raw_affiliation_strings":["Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"Royal Marsden NHS Trust, Sutton, SM2 5PT, Surrey, UK","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112780032","display_name":"M. Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150388","display_name":"Velindre Cancer Centre","ror":"https://ror.org/049sr1d03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799279586","https://openalex.org/I4210150388"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Mason","raw_affiliation_strings":["Department of Clinical Oncology, Velindre Hospital, Whitchurch, Cardiff, CF4 7XL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Velindre Hospital, Whitchurch, Cardiff, CF4 7XL, UK","institution_ids":["https://openalex.org/I4210150388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109897992","display_name":"S.J. Harland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Harland","raw_affiliation_strings":["Department of Oncology, University College of London, The Middlesex Hospital Mortimer St, London, W1N 8AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University College of London, The Middlesex Hospital Mortimer St, London, W1N 8AA, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Robbins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Robbins","raw_affiliation_strings":["Drug Development Office, Cancer Research UK, PO Box 123, London, WC2A 3PX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Office, Cancer Research UK, PO Box 123, London, WC2A 3PX, UK","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075397179","display_name":"Gavin Halbert","orcid":"https://orcid.org/0000-0001-8553-3647","observed_orcids":["https://orcid.org/0000-0001-8553-3647"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Halbert","raw_affiliation_strings":["Cancer Research UK Formulation Unit, University of Strathclyde, Glasgow, G1 1XW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Formulation Unit, University of Strathclyde, Glasgow, G1 1XW, UK","institution_ids":["https://openalex.org/I181647926","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075006320","display_name":"Bernard P. Nutley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B Nutley","raw_affiliation_strings":["CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043283673","display_name":"Michael Jarman","orcid":"https://orcid.org/0009-0000-7228-7213","observed_orcids":["https://orcid.org/0009-0000-7228-7213"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Jarman","raw_affiliation_strings":["CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, SM2 5NG, Surrey, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5053304892"],"corresponding_institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.5285,"has_fulltext":true,"cited_by_count":381,"citation_normalized_percentile":{"value":0.89906292,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"90","issue":"12","first_page":"2317","last_page":"2325"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8579999804496765},{"id":"https://openalex.org/keywords/testosterone-suppression","display_name":"testosterone suppression","score":0.7950000166893005},{"id":"https://openalex.org/keywords/luteinizing-hormone","display_name":"luteinizing hormone","score":0.8650000095367432},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/castration","display_name":"castration","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.4440000057220459},{"id":"https://openalex.org/keywords/glucocorticoid-replacement-therapy","display_name":"glucocorticoid replacement therapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/second-line-hormonal-therapy","display_name":"second-line hormonal therapy","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.9215294122695923},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6309130191802979},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5469818115234375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5005598068237305},{"id":"https://openalex.org/C2776421732","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone","level":5,"score":0.46900439262390137},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4589901566505432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43086913228034973},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4285314083099365},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42739906907081604},{"id":"https://openalex.org/C142716871","wikidata":"https://www.wikidata.org/wiki/Q408305","display_name":"CYP17A1","level":3,"score":0.42354488372802734},{"id":"https://openalex.org/C2777269803","wikidata":"https://www.wikidata.org/wiki/Q407727","display_name":"Lyase","level":3,"score":0.41968464851379395},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3519270420074463},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.288820743560791},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19958359003067017},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.0},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000069501","descriptor_name":"Abiraterone Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002369","descriptor_name":"Castration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007986","descriptor_name":"Luteinizing Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013739","descriptor_name":"Testosterone","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjc.6601879","doi":"https://doi.org/10.1038/sj.bjc.6601879","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6601879","pdf_url":"https://www.nature.com/articles/6601879.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2409523","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2409523","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:15150570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15150570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:strathprints.strath.ac.uk:38542","doi":null,"is_oa":false,"landing_page_url":"https://strathprints.strath.ac.uk/38542/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6601879","doi":"https://doi.org/10.1038/sj.bjc.6601879","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6601879","pdf_url":"https://www.nature.com/articles/6601879.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2171041379.pdf","grobid_xml":"https://content.openalex.org/works/W2171041379.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1740737174","https://openalex.org/W1782483823","https://openalex.org/W1947561494","https://openalex.org/W1991074325","https://openalex.org/W1993808852","https://openalex.org/W2000305296","https://openalex.org/W2002372801","https://openalex.org/W2017232259","https://openalex.org/W2027081726","https://openalex.org/W2039018201","https://openalex.org/W2051460847","https://openalex.org/W2058818042","https://openalex.org/W2064360128","https://openalex.org/W2076915947","https://openalex.org/W2079470488","https://openalex.org/W2110155536","https://openalex.org/W2117325725","https://openalex.org/W2134825260","https://openalex.org/W2138684882","https://openalex.org/W4233610788","https://openalex.org/W4239393784"],"related_works":["https://openalex.org/W7019569979","https://openalex.org/W2078222208","https://openalex.org/W2525520624","https://openalex.org/W2078310414","https://openalex.org/W3145939398","https://openalex.org/W2113569308","https://openalex.org/W3009079267","https://openalex.org/W2055944905","https://openalex.org/W2107579903","https://openalex.org/W3006285711"],"abstract_inverted_index":{"A":[0,37],"series":[1],"of":[2,13,23,103,115,124,143,152,160,198,201,210,222,237,250,278],"three":[3,141,144,161],"dose":[4,41,51,62,75,123,173,221],"escalating":[5],"studies":[6],"were":[7],"conducted":[8],"to":[9,19,28,80,106,149,179,230,247],"investigate":[10],"the":[11,14,171,195,199,231],"ability":[12],"17alpha-hydroxylase/C(17,20)-lyase":[15],"inhibitor":[16,205],"abiraterone":[17,217],"acetate,":[18],"cause":[20],"maximum":[21],"suppression":[22,137,164,238,255,273],"testosterone":[24,104,228,254],"synthesis":[25],"when":[26],"delivered":[27],"castrate":[29,44,117,232,258],"and":[30,56,76,85],"noncastrate":[31,54,65,134],"males":[32,55,118],"with":[33,97,120,212,216],"prostate":[34,270],"cancer.":[35,271],"Study":[36,46],"was":[38,48,59,69,94,110,138],"a":[39,49,60,73,121,147,180,202,220,265],"single":[40,50,122],"study":[42,52,57,63,92,174,263],"in":[43,53,64,72,88,100,112,133,140,157,170,206,243,257],"males.":[45,66],"B":[47],"C":[58],"multiple":[61,172],"The":[67,91,252],"drug":[68,93],"given":[70,130],"orally":[71],"once-daily":[74],"blood":[77],"samples":[78],"taken":[79],"assess":[81],"pharmacokinetic":[82],"(PK)":[83],"parameters":[84],"hormone":[86],"levels":[87,105,156,190,229],"all":[89,244],"patients.":[90],"well":[95],"tolerated":[96],"some":[98],"variability":[99],"PKs.":[101],"Suppression":[102],"<0.14":[107],"nmol":[108],"l(-1)":[109],"seen":[111],"four":[113],"out":[114,142,159],"six":[116],"treated":[119],"500":[125],"mg.":[126],"At":[127],"800":[128,223],"mg":[129,224],"days":[131],"1-12":[132],"males,":[135],"target":[136],"achieved":[139,256],"patients,":[145],"but":[146],"two-":[148],"three-fold":[150],"increase":[151],"Luteinising":[153],"Hormone":[154],"(LH)":[155],"two":[158],"patients":[162,169,245],"overcame":[163],"within":[165],"3":[166],"days.":[167],"All":[168],"developed":[175],"an":[176],"abnormal":[177],"response":[178],"short":[181],"Synacthen":[182],"test":[183],"by":[184],"day":[185],"11,":[186],"although":[187],"baseline":[188],"cortisol":[189],"remained":[191],"normal.":[192],"This":[193],"is":[194],"first":[196],"report":[197],"use":[200],"specific":[203],"17alpha-hydroxylase/(17,20)-lyase":[204],"humans.":[207],"Repeated":[208],"treatment":[209,268],"men":[211,259],"intact":[213],"gonadal":[214],"function":[215],"acetate":[218],"at":[219],"can":[225],"successfully":[226],"suppress":[227],"range.":[233],"However,":[234],"this":[235],"level":[236],"may":[239,274],"not":[240],"be":[241],"sustained":[242],"due":[246],"compensatory":[248],"hypersecretion":[249],"LH.":[251],"enhanced":[253],"merits":[260],"further":[261],"clinical":[262],"as":[264],"second-line":[266],"hormonal":[267],"for":[269],"Adrenocortical":[272],"necessitate":[275],"concomitant":[276],"administration":[277],"replacement":[279],"glucocorticoid.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":34},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":32},{"year":2013,"cited_by_count":33},{"year":2012,"cited_by_count":40}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}